Anti-diabetic activity of quercetin extracted from Phyllanthus emblica L. fruit: In silico and in vivo approaches

M. Riaz, M. Zia-Ul-Haq, B. Saad, The role of anthocyanins in obesity and diabetes, Anthocyanins and Human Healthy: Biomolecular and therapeutic aspects, Springer Briefs in food, Health, and Nutrition, Springer, 2016: 109–123.

Kuzuya, 2002, Report of the Committee on the classification and diagnostic criteria of diabetes mellitus, Diabetes Res. Clin. Pract., 1, 65, 10.1016/S0168-8227(01)00365-5

Wild, 2004, Global prevalence of diabetes: estimates for the year 2000 and projections for 2030, Diabetes Care, 27, 1047, 10.2337/diacare.27.5.1047

Liu, 2013, Antihyperglycemic, antihyperlipidemic and antioxidant activities of polysaccharides from Catathelasma ventricosum in streptozotocin-induced diabetic mice, Food Chem. Toxicol., 57, 39, 10.1016/j.fct.2013.03.001

Vilsboll, 2004, lncretins, insulin secretion and Type 2 diabetes mellitus, Diabetologia, 47, 357, 10.1007/s00125-004-1342-6

World Health Organization, Chronicle, 1985.

Valiathan, 1998, Healing plants, Curr. Sci., 75, 1122

Santosh kumar, 2013, Study of anti-inflammatory activity of fruit of Emblica officinalis (Amla) in Albino rats, Med. Innov., 2, 17

Duan, 2005, Anti-atherogenic effects of Phyllanthus emblica associated with corilagin and its analogue, Yakugaku Zasshi, 125, 587, 10.1248/yakushi.125.587

Madhuri, 2011, Antioxidant, immunomodulatory and anticancer activities of Emblica officinalis: an overview, Int. Res. J. Pharm., 2, 38

Krishnaveni, 2010, Therapeutic potential of Phyllanthus emblica (amla): the ayurvedic wonder, J. Basic. Clin. Physiol. Pharmacol., 21, 93, 10.1515/JBCPP.2010.21.1.93

Unander, 1990, Records of usage or assays in Phyllanthus (Euphorbiaceae). I. Subgenera Isocladus, Kirganelia, Cicca and Emblica, J. Ethnopharmacol., 30, 233, 10.1016/0378-8741(90)90105-3

Schrödinger, LLC, New York, NY, 2015.

〈http://www.chemspider.com〉.

〈http://www.rcsb.com〉.

Glide v5.7, Schrödinger, LLC, New York, 2011.

LigPrep v2.5, Schrödinger, LLC, New York, 2011.

Kemp, 1954, A colorimetric micro-method for the determination of glycogen in tissues, Biochem. J., 56, 646, 10.1042/bj0560646

McCormack, 2001, Pharmacological approaches to inhibit endogenous glucose production as a means of anti-diabetic therapy, Curr. Pharm. Des., 7, 1451, 10.2174/1381612013397393

Treadway, 2001, Glycogen phosphorylase inhibitors for treatment of type 2 diabetes mellitus, Expert. Opin. Investig. Drugs, 10, 439, 10.1517/13543784.10.3.439

Sarabu, 2005, Recent advances in therapeutic approaches to type 2 diabetes, Annu. Rep. Med. Chem., 40, 167

Paramaguru, 2014, Antidiabetic activity of Pterospermum acerifolium flowers and glucose uptake potential of bioactive fraction in L6 muscle cell lines with its HPLC fingerprint, BioMed. Res. Int., 1, 10.1155/2014/459376

Hui, 2009, Hypoglycemic herbs and their action mechanisms, Chin. Med., 4, 11, 10.1186/1749-8546-4-11

Neustadt, 2008, Medication-induced mitochondrial damage and disease, Mol. Nutr. Food Res., 52, 780, 10.1002/mnfr.200700075

Bibi, 2013, Ligand based approach for pharmacophore generation for identification of novel compounds having anti-diabetic activity, Int. J. Pharm. Sci., 4, 303

Sundaram, 2013, Modulatory effect of green tea extract on hepatic key enzymes of glucose metabolism in streptozotocin and high fat diet induced diabetic rats, Phytomedicine, 20, 577, 10.1016/j.phymed.2013.01.006

Coskun, 2005, Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas, Pharmacol. Res., 51, 117, 10.1016/j.phrs.2004.06.002

Tiwari, 2002, Diabetes mellitus and multiple therapeutic approaches of phytochemicals: present status and future prospects, Curr. Sci., 83, 30

Torres-Piedra, 2010, A Comparative study of flavonoid nalogues on streptozotocin-nicotinamide induced diabetic rats: quercetin as a potential antidiabetic agent acting via 11beta-hydroxysteroid dehydrogenase type 1 inhibition, Eur. J. Med. Chem., 45, 2606, 10.1016/j.ejmech.2010.02.049

DeFronzo, 1999, Pharmacologic therapy for type 2 diabetes mellitus, Ann. Intern. Med., 131, 281, 10.7326/0003-4819-131-4-199908170-00008

Arias, 2014, Quercetin can reduce insulin resistance without decreasing adipose tissue and skeletal muscle fat accumulation, Genes. Nutr., 9, 361, 10.1007/s12263-013-0361-7

Kim, 2011, Quercetin attenuates fasting and postprandial hyperglycemia in animal models of diabetes mellitus, Nutr. Res. Pract., 5, 107, 10.4162/nrp.2011.5.2.107

Mohammadi, 2008, Evaluation of hypoglycemic effect of Morus alba in an animal model, Indian J. Pharmacol., 40, 15, 10.4103/0253-7613.40483

Nuraliev, 1992, The efficacy of quercetin in alloxan diabetes, Exp. Clin. Pharmacol., 55, 42

Guo, 2014, Hypoglycemic and hypolipidemic effects of oxymatrine in high-fat diet and streptozotocin-induced diabetic rats, Phytomedicine, 21, 807, 10.1016/j.phymed.2014.02.007

Vessal, 2003, Antidiabetic effects of quercetin in streptozotocin induced diabetic rats, Comp. Biochem. Physiol. Toxicol. Pharmacol., 135, 357, 10.1016/S1532-0456(03)00140-6